Home
Public services
Dashboard
Curated content
Companies
Job board
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Companies
QED Therapeutics
Save
QED Therapeutics
A biotechnology company focused on precision medicine for FGFR-driven disorders.
Launch date
2018
Employees
11-50 people
Market cap
-
Enterprise valuation
CAD355—532m
(Dealroom.co estimates Jan 2018.)
Palo Alto California (HQ)
http://qedtx.com
https://www.linkedin.com/company/qed-therapeutics
B2B
manufacturing
commission
health
biotechnology
hard tech
biotechnology
biotech and pharma
oncology
precision medicine
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (4)
QED Therapeutics funding
QED Therapeutics investors
Edit
Date
Investors
Amount
Round
Jan 2018
BridgeBio
$65.0m
Late VC
Total Funding
CAD88.6m
Related Content
Recent News about QED Therapeutics
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access